Board Welcomes Sullivan as Chair, Elkus and Herrling as New Trustees
The Scripps Research Institute (TSRI) Board of Trustees welcomed retired judge Alice D. Sullivan as its new chair and two industry leadersSillicon Valley entrepreneur Richard J. Elkus, Jr. and Novartis head of Corporate Research Paul Herrlingas new trustees.
Chair of the Board Hon. Alice D. Sullivan (Ret.)
Sullivan is founder and chief executive officer of Private Judge, a firm in Del Mar that provides expertise in the resolution of business disputes, particularly in the life science and technology fields. Over the last 10 years, she has mediated over 1,000 cases and has served as an arbitrator in more than 100 cases.
In addition, Sullivan is a frequent lecturer and trainer in mediation and civil law topics, speaking at such institutions as Santa Clara University, Del Mar Foundation, The Rutter Group, San Diego Intellectual Property Law Association, Department of Commerce/Federal Trade Commission, American Bar Association, and The State Bar of California.
While welcoming Sullivan to the position of chair, the Board unanimously passed a resolution expressing its appreciation to outgoing chair John D. Diekman, whose leadership was "marked by deep dedication, unflagging energy, and great enthusiasm."
Trustee Richard J. Elkus Jr.
His current positions include:
Previously, he was chair and CEO of Prometrix Corporation, which he co-founded in 1983. Prometrix revolutionized the concept of computerized wafer mapping that is now fundamental to the analysis of wafer development and production in the semiconductor manufacturing process. Prometrix merged with Tencor and later with KLA, becoming KLA-Tencor.
From 1985 to 1992 Elkus was director and finally chair of Integrated Systems, Inc. Prior to that, he held positions at Geometrics and Acacia Sales. After graduating from Stanford University and Dartmouth College's Tuck School of Business Administration, Elkus spent the first 10 years of his career at Ampex Corporation, where he wrote the original product plan and headed the team that introduced the VCR in September 1970.
Trustee Paul Herrling
Prior to his current position at Novartis, Herrling was head of Global Research at Novartis Pharma and a member of the Pharma Executive Committee. In this capacity, he directed the integration of the research organizations of Sandoz and Ciba-Geigy following their merger in 1996. Herrling had joined Sandoz in 1975, rising to head of Corporate Research by 1994.
In addition, Herrling, who obtained his doctorate in 1975 from the University of Zurich, is professor of Drug Discovery Science at the University of Basel, Switzerland and adjunct professor at TSRI's Harold L. Dorris Neurological Research Center.
Herrling serves on the boards of a number of institutions, including: the Genomics Institute of the Novartis Research Foundation in La Jolla, the Board of Trustees Novartis Foundation in London, Board of Trustees Foundation Maison de la Chimie in Paris, and the TSRI-Novartis Joint Scientific Council in La Jolla.